Frontiers in Immunology publication, Saura-Esteller, et al.
Month: June 2022
Phase I dose escalation of LAVA-051, a novel bispecific γδ-T cell engager (Gammabody™), in relapsed/refractory hematological malignancies
European Hematological Association (EHA) 2022 Congress presentation Broijl, et al.
Phase I dose escalation of LAVA-051, a novel bispecific gamma delta T-cell engager (Gammabody™), in relapsed/refractory hematological malignancies
2022 American Society of Clinical Oncology (ASCO) Annual Meeting presentation
Brojil, et al.